Seikagaku Corporation operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Seikagaku with three other
companies in this sector in Japan:
Eiken Chemical Co., Ltd.
sales of 32.16 billion Japanese Yen [US$311.02 million]
of which 56%
was Immunoserology Test Agent),
Nippon Chemiphar Co., Ltd.
(35.60 billion Japanese Yen [US$344.27 million]
of which 97%
was Pharmaceutical Business), and
Aska Pharmaceutical Company Limited
(43.22 billion Japanese Yen [US$417.89 million]
of which 90%
was Pharmaceutical Products Business).
Seikagaku reported sales of ¥30.96 billion (US$299.40 million)
March of 2016.
increase of 4.9%
versus 2015, when the company's sales were ¥29.52 billion.
Sales of Lal saw an increase
that was more than double the company's growth rate: sales were up
11.6% in 2016, from
¥4.88 billion to ¥5.44 billion.